Bone Marrow TransplantationTransplantation, AutologousTransplantation, HomologousBone MarrowBone Marrow CellsHematopoietic Stem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningLiver TransplantationWhole-Body IrradiationGraft SurvivalKidney TransplantationStem Cell TransplantationBone Marrow PurgingBone and BonesTransplantation ChimeraBusulfanLeukemiaTissue DonorsAnemia, AplasticHematopoietic Stem CellsCombined Modality TherapyCyclophosphamideTreatment OutcomeMultiple MyelomaRecurrenceHistocompatibility TestingHeart TransplantationLymphoma, Non-HodgkinMelphalanTransplantation, IsogeneicRemission InductionHistocompatibilityLung TransplantationHematologic NeoplasmsGraft RejectionImmunosuppressive AgentsHematopoiesisPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell MobilizationTime FactorsCell TransplantationTransplantation ImmunologyCarmustineLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsSurvival AnalysisAntigens, CD34Retrospective StudiesBone Marrow DiseasesGranulocyte Colony-Stimulating FactorOrgan TransplantationMice, Inbred C57BLSalvage TherapyImmunosuppressionDisease-Free SurvivalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraEtoposideSurvival RateCytarabineColony-Forming Units AssayGraft vs Tumor EffectFollow-Up StudiesMyelodysplastic SyndromesHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone Marrow ExaminationLeukemia, MyeloidAcute DiseaseCell DifferentiationT-LymphocytesGraft vs Host ReactionLymphocyte DepletionPancreas TransplantationIslets of Langerhans TransplantationHLA AntigensBone RemodelingCells, CulturedLeukocyte TransfusionBone Marrow NeoplasmsCyclosporineTransplantationLymphomaLeukapheresisSevere Combined ImmunodeficiencyPrognosisChimeraFlow CytometryCord Blood Stem Cell TransplantationActuarial AnalysisLymphocyte TransfusionCell SeparationHematologic DiseasesMesenchymal Stromal CellsLiving DonorsNeoplasm, ResidualCytomegalovirus InfectionsTransplantation Tolerance